Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate Plus Rosuvastatin in Atypical Endometrial Hyperplasia
NCT04491682Phase 3Completed
- Sponsor
- Fudan University
- Start
- Sep 2020
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in Atypical endometrial hyperplasia (AEH), sponsored by Fudan University. Started Sep 2020; status: completed.
02
Drugs
rosuvastatin
03
Conditions
Atypical endometrial hyperplasia (AEH)
Beyond the preview
Go deeper on NCT04491682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04491682.